2025 Parathyroid Hormone Market Outlook: Key Indicators Shaping Growth Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Parathyroid Hormone Industry Market Size Be by 2025?
The market size for parathyroid hormone has seen consistent growth in the recent past. It is projected to escalate from $2.35 billion in 2024 to $2.43 billion in 2025, with a 3.5% compound annual growth rate (CAGR). Contributing factors to this upward trend in the historic period include an increased incidence of chronic kidney disease, heightened awareness of disorders related to parathyroid hormone, a surge in demand for parathyroid hormone analogs, increased government investment in parathyroid hormone research, and rising disposable incomes.

What's the Long-Term Growth Forecast for the Parathyroid Hormone Market Size Through 2029?
The market for parathyroid hormone is projected to witness significant expansion in the coming years, surging to $3.5 billion by 2029 with a consistent compound annual growth rate (CAGR) of 9.6%. Factors contributing to this growth during the forecast period include the increasing elder population, the enlargement of the private healthcare industry, the rise of new indications, precision medicine, heightened bone health cognizance, and broader healthcare availability. Key trends during the prediction period cover improvements in parathyroid hormone testing, progress in drug delivery, the implementation of combination therapies, digital health assimilation, and initiatives of sustainability and environmental consciousness.

View the full report here:
https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

What Are the Key Growth Drivers Fueling the Parathyroid Hormone Market Expansion?
The escalating cases of osteoporosis are anticipated to fuel the demand for parathyroid hormones in the market. Characterized by a decline in bone mass and degradation of bone tissue, osteoporosis increases the susceptibility to fractures. The International Osteoporosis Foundation reported in January 2023 that roughly 1.4 million Canadians, primarily postmenopausal women and older people, are impacted by osteoporosis. The parathyroid hormone, which is a natural bodily secretion for managing calcium levels, is employed to mitigate fracture risk in osteoporosis patients and is administered via a daily subcutaneous injection. Hence, the surge in osteoporosis cases is likely to stimulate the expansion of the parathyroid hormone market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3427&type=smp

What Are the Key Trends Driving Parathyroid Hormone Market Growth?
Key players in the parathyroid hormone industry are concentrating on the creation of biosimilars for parathyroid-derived medications, such as parathyroid hormone (PTH) prodrugs, in order to expand therapeutic possibilities. A parathyroid hormone prodrug is an inactive substance that is activated post-administration, enabling sustained release and a stable therapeutic response related to calcium balance and bone health. For example, Ascendis Pharma A/S, a biopharmaceutical company from Denmark, reported in August 2024 that the Food & Drug Administration (FDA) approved YORVIPATH (palopegteriparatide) as the sole and first treatment for adult hypoparathyroidism. This daily prodrug allows continuous exposure to PTH for around 70,000 to 90,000 patients in the U.S. Ascendis Pharma, the producer, offers patient assistance through its Ascendis Signature Access Program (A.S.A.P.), but it requires users to consistently observe serum calcium levels to guard against potential hypercalcemia or hypocalcemia.

How Is the Parathyroid Hormone Market Segmented?
The parathyroid hormone market covered in this report is segmented -

1) By Disease Type: Hypocalcemia, Hypoparathyroidism
2) By Product Type: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues
3) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:
1) By Hypocalcemia: Pseudohypoparathyroidism, Vitamin D Deficiency
2) By Hypoparathyroidism: Post-Surgical Hypoparathyroidism, Idiopathic Hypoparathyroidism

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3427&type=smp

Which Companies Are Leading the Charge in Parathyroid Hormone Market Innovation?
Major companies operating in the parathyroid hormone market include Pfizer Inc., Eli Lilly and Company, Radius Health Inc., Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc., Gedeon Richter Plc., Abbott Laboratories, Amgen Inc., Merck & Co. Inc., Novartis AG, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd., Alcon Laboratories Inc., Bayer Healthcare, AstraZeneca PLC, Biocon, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Jubilant Life Sciences, Lupin Limited, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Wockhardt, Cipla Limited

Which Regions Are Leading the Global Parathyroid Hormone Market in Revenue?
The countries covered in the parathyroid hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3427

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.